Stay updated on Efficacy of Azeliragon in Mild Alzheimer's Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Azeliragon in Mild Alzheimer's Clinical Trial page.

Latest updates to the Efficacy of Azeliragon in Mild Alzheimer's Clinical Trial page
- Check4 days agoChange DetectedA banner announces an NIH-wide transition in terminology from “Artificial Intelligence” to “Super Intelligence.” The page continues to display a 403 error instead of the study record.SummaryDifference1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe site revision identifier in the page footer changed from v3.7.0 to v3.7.1, while the study record continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check39 days agoChange DetectedThe page’s revision label was updated from v3.6.6 to v3.7.0, indicating a system update. This change does not modify trial details, outcomes, or eligibility requirements.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page's revision label was updated from v3.6.5 to v3.6.6, signaling a small maintenance update to the page version without altering the study information.SummaryDifference0.0%

- Check74 days agoChange DetectedThe study documents now reference Revision: v3.6.5, replacing v3.6.4, signaling an updated protocol/analysis plan for the STEADFAST trial.SummaryDifference0.0%

- Check96 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4 in the page's revision history. This reflects a maintenance/build update and does not modify the study details or other user-facing information.SummaryDifference0.0%

Stay in the know with updates to Efficacy of Azeliragon in Mild Alzheimer's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Azeliragon in Mild Alzheimer's Clinical Trial page.